Colorectal cancer is one of the most common tumors among people over the age of 50. Although it is known to develop from ...

Research reveals that the combination of palbociclib and telaglenastat, two drugs with complementary actions, could help ...

Researchers believe a groundbreaking new drug can offer hope to those diagnosed with this deadly breast cancer, creating a ...

Scientists at UCSF identified a key cellular switch that plays a large role in pulmonary fibrosis, and found a way of ...

Colorectal cancer is one of the most common tumours among people over the age of 50. Although it is known to develop from ...

Biosynthesis requires energy, typically in the form of ATP (adenosine triphosphate), and enzymes to catalyze the reactions.

The American Cancer Society tracks survival rates for 22 types of localized cancer, including the most common in the US: prostate (100%), skin (99.6% five-year survival rate), breast (99.3%), lung (65 ...

Enhertu significantly improved IDFS compared to Kadcyla, with a 53% risk reduction in invasive disease or death in high-risk, ...

Basel, 23 October 2025 Group sales grew by 7%1 at constant exchange rates (CER; 2% in CHF) in the first nine months, driven by high demand for our innovative medicines and diagnostics.Pharmaceuticals ...

Discusses ESMO Data on TGF-beta Receptor by PD-1 Bispecific in Colorectal Cancer and G12D Inhibitor in Pancreatic ...